Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kunitada

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 20, 2000
[FXa inhibitor]S Kunitada
European Journal of Pharmacology|May 15, 1978
The plasma cyclic AMP response to catecholamines as potentiated by phentolamine in ratsS Kunitada, M Ui
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1989
Functional and metabolic effects of bucladesine (dibutyryl cyclic AMP) in the working rat heart preparation: comparison with dopamineH Hashimoto, S Kunitada, K Tamura
European Journal of Pharmacology|March 15, 1978
Increases in plasma cyclic AMP dependent on endogenous catecholaminesS Kunitada, M Honma, M Ui
Blood|March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retractionS Kunitada, G A FitzGerald, D J Fitzgerald
Thrombosis Research|October 1, 1995
Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitorT Hara, A Yokoyama, Y Morishima, et al.
Thrombosis and Haemostasis|January 4, 1998
Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulantsY Morishima, K Tanabe, Y Terada, et al.
Thrombosis Research|March 14, 2000
A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in ratsB Kaiser, M Paintz, O Scholz, et al.
Thrombosis Research|November 26, 1999
A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor induced disseminated intravascular coagulation in ratsK Tanabe, Y Terada, T Shibutani, et al.
European Journal of Pharmacology|January 14, 1992
A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathyH Masumura, S Kunitada, K Irie, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 20, 2000
[FXa inhibitor]S Kunitada
European Journal of Pharmacology|May 15, 1978
The plasma cyclic AMP response to catecholamines as potentiated by phentolamine in ratsS Kunitada, M Ui
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1989
Functional and metabolic effects of bucladesine (dibutyryl cyclic AMP) in the working rat heart preparation: comparison with dopamineH Hashimoto, S Kunitada, K Tamura
European Journal of Pharmacology|March 15, 1978
Increases in plasma cyclic AMP dependent on endogenous catecholaminesS Kunitada, M Honma, M Ui
Blood|March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retractionS Kunitada, G A FitzGerald, D J Fitzgerald
Thrombosis Research|October 1, 1995
Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitorT Hara, A Yokoyama, Y Morishima, et al.
Thrombosis and Haemostasis|January 4, 1998
Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulantsY Morishima, K Tanabe, Y Terada, et al.
Thrombosis Research|March 14, 2000
A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in ratsB Kaiser, M Paintz, O Scholz, et al.
Thrombosis Research|November 26, 1999
A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor induced disseminated intravascular coagulation in ratsK Tanabe, Y Terada, T Shibutani, et al.
European Journal of Pharmacology|January 14, 1992
A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathyH Masumura, S Kunitada, K Irie, et al.
Pageof 2